Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Of Atrial Fibrillation Article
This is a selection made from among articles on Drug Treatment Of Atrial Fibrillation. For a permanent link to this article, or to bookmark it for future reading, click here.
What Everyone Ought To Know About Alcoholism Recovery
from: Alcoholism is one of the most common addictions in the present-day world. Once an alcoholic has identified him or herself as such, then it’s time that they reach out for help for their addiction. In many cases, the alcoholic’s family or friends have to take the first step in getting the addicted person into a recovery state. Sometimes an intervention is staged, where the alcoholic is given an ultimatum: go to rehab or get out of our lives. Other times, simply speaking concern to the alcoholic can snap them back to reality and make them realize that their addiction has progressed into a disease and is affecting others.Once an alcoholic is ready to seek help for his or her addiction, he or she must choose how to stop drinking. One of the more popular ways to rehabilitate an alcoholic is by implementing detoxification. Detox is going “cold turkey;” this is when an alcoholic abruptly stops drinking alcohol. Also, this cold turkey approach is used in conjunction with different drugs which are used to minimize withdrawal symptoms. Detox happens in a rehabilitation center setting; this is where a detox may be the most effective, as rehab centers are fully stocked with the drugs and staff needed to help an addict get off of his or her drug.
Detox can happen in many different ways, depending upon the degree of addiction present in the alcoholic. Drug treatment centers use detoxification to help to treat the physical effects of prolonged alcohol use, but it doesn’t treat the actual disease of alcoholism. At a drug treatment center, detox commonly takes about a week to complete; after this time, the patient will not experience the extreme physical withdrawal symptoms. After a patient is finished with detox, relapse may occur, especially if the recovering alcoholic receives no further addiction treatment.
One further treatment that many alcoholics participate in at rehab centers and elsewhere is group therapy or psychotherapy to help combat the mental ailing that often accompanies rehab from alcohol. These group therapy meetings will also give the recovering alcoholic the tools that he or she needs to combat his or her addiction and prevent relapse. The most popular group therapy is Alcoholics Anonymous, but there are many other support groups to aide in addiction recovery.
However an alcoholic gets addiction help, it’s important that he or she follow their rehabilitation through to the end. There is help out there for the addicted to come clean; it’s just a matter of him or her finding it.
About Author
Addiction.com is an admired resource for those struggling with an addiction. Addicted.com offers widespread information regarding how to choose a drug treatment center that is right for you.
Source: ArticleTrader.com
Drug Treatment Of Atrial Fibrillation Specific links
Drug Treatment Of Atrial Fibrillation News
Study Reports Catheter Ablation Superior to Drug Therapy as First-Line ... - MarketWatch (press release)
Study Reports Catheter Ablation Superior to Drug Therapy as First-Line ... MarketWatch (press release) BOSTON, May 11, 2012 (BUSINESS WIRE) -- Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving antiarrhythmic drugs, ... Heart Procedure More Effective Than Drug for Erratic Rate Ablation Could Be First-Line Afib Therapy Cardiac Ablation Superior for Afib Therapy |
U.S FDA advisers rebuff J&J/Bayer Xarelto heart drug - Chicago Tribune
 The Star-Ledger - NJ.com | U.S FDA advisers rebuff J&J/Bayer Xarelto heart drug Chicago Tribune It is also approved to prevent strokes among people with a type of irregular heartbeat called atrial fibrillation. But the companies wanted to expand its use to treat acute coronary syndrome, which refers to people who have heart attacks or chest pain, ... FDA Panel Votes Against Expanded Approval Of Bayer, J&J's Xarelto FDA Panel Votes Against J&J And Bayer Bloodthinner For ACS FDA advisors recommend against new use for Johnson & Johnson's blood-thinner ... |
Bayer-J&J Heart Drug Gains Further Support - Wall Street Journal
 WWLP 22News | Bayer-J&J Heart Drug Gains Further Support Wall Street Journal Xarelto, considered part of a new generation of blood-thinning drugs, was approved last year to prevent strokes in patients with a heart-rhythm disorder called atrial fibrillation and is also approved for short-term use in patients undergoing knee- or ... FDA Panel Votes Against Expanded Approval Of Bayer, J&J's Xarelto US advisers reject J&J/Bayer's Xarelto for acute coronary patients FDA Panel Votes Against Expanding Use of an Anticoagulant |
"The future of AF ablation catheter technologies": A New Report Reveals the ... - MarketWatch (press release)
"The future of AF ablation catheter technologies": A New Report Reveals the ... MarketWatch (press release) PALO ALTO, Calif., May 02, 2012 (BUSINESS WIRE) -- Design and technology consultancy Cambridge Design Partnership today announces that it has completed a research project to identify the future of medical technology to treat Atrial Fibrillation; ... |
Atrial Fibrillation - New Treatment Shows Promise - Medical News Today
Atrial Fibrillation - New Treatment Shows Promise Medical News Today According to the design and technology consultancy Cambridge Design Partnership, their research project to identify the future of medical technology to treat Atrial Fibrillation has been completed. The report is designed to explore the emerging ... |
DC Week: FDA User Fee Bill Gets Senate OK - MedPage Today
 MedPage Today | DC Week: FDA User Fee Bill Gets Senate OK MedPage Today Rivaroxaban already has FDA marketing approval for prevention of stroke in patients with nonvalvular atrial fibrillation and for prevention of deep vein thrombosis in patients undergoing joint replacement surgery. Wednesday's panel seemed in agreement ... |
Non-Surgical Procedure Offers Patients with Atrial Fibrillation Who Cannot ... - MarketWatch (press release)
Non-Surgical Procedure Offers Patients with Atrial Fibrillation Who Cannot ... MarketWatch (press release) Patients with atrial fibrillation (A-fib) who cannot take blood thinners now have an alternative to reduce their risk of stroke, which is five times more common in people with the rhythm disorder. The non-surgical procedure works by tying off the left ... |
Pradaxa Patients Can't Stop the Bleeding - Houston Press
Pradaxa Patients Can't Stop the Bleeding Houston Press Like hundreds of thousands of others with a heart condition called atrial fibrillation, which raises the risk of stroke, Franklin had been told of the benefits of the recently FDA-approved Pradaxa over its comparatively ancient counterpart, Coumadin. |
Boehringer Ingelheim Announces Launch of GLORIA(TM)-AF Registry in Newly ... - MarketWatch (press release)
Boehringer Ingelheim Announces Launch of GLORIA(TM)-AF Registry in Newly ... MarketWatch (press release) "With the launch of GLORIA-AF, Boehringer Ingelheim continues to broaden the understanding of non-valvular atrial fibrillation," said John Smith, MD, Ph.D., senior vice president for clinical development and medical affairs, Boehringer Ingelheim ... |
FDA Panel Votes Against New Use for Blood Thinner Xarelto - U.S. News & World Report
 Daily Mail | FDA Panel Votes Against New Use for Blood Thinner Xarelto U.S. News & World Report Xarelto is already approved for use by those with atrial fibrillation (irregular heartbeat) and by people who are having hip- or knee-replacement surgery. In the FDA briefing documents released Monday, an agency reviewer recommended approving the drug ... One-a-day pill offers new hope on strokes: Up to 900000 could benefit as drug ... NHS GETS GO-AHEAD FOR STROKE SUPERPILL NICE final "yes" to Xarelto |